NCT01473576

Brief Summary

A diet rich in leafy green vegetables has been shown to reduce the risk of developing chronic metabolic disease. The health benefits from these particular vegetables may be attributed to their high nitrate content. Recent work suggests that dietary nitrate triggers endogenous nitric oxide release, thereby stimulating vasodilation and improving muscle perfusion in an insulin-independent manner. We hypothesize that in an insulin-resistant state, nitrate co-ingestion will increase muscle perfusion, thereby improving post-prandial delivery of nutrients to skeletal muscle tissue. Specifically, a more efficient delivery of food derived amino acids will stimulate post-prandial muscle protein synthesis and, as such, compensate for a blunted muscle protein synthetic response to food intake in the elderly. This proposal will investigate the efficacy of nitrate co-ingestion as a means to augment muscle protein synthesis in elderly, type 2 diabetes patients and may lead to a novel therapy in the clinical care of type 2 diabetes patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2011

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2011

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 3, 2011

Completed
14 days until next milestone

First Posted

Study publicly available on registry

November 17, 2011

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2012

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

April 15, 2016

Status Verified

October 1, 2012

Enrollment Period

11 months

First QC Date

November 3, 2011

Last Update Submit

April 14, 2016

Conditions

Keywords

type II diabetesprotein synthesisnitrateelderly

Outcome Measures

Primary Outcomes (1)

  • Muscle protein fractional synthetic rate

    Muscle protein fractional synthetic rate assessed using the muscle biopsy technique.

    -2, 0, +2, +5 h during the trial

Secondary Outcomes (2)

  • Plasma amino acids

    every 30 min (from -2 h to + 5 h during the test day)

  • Plasma nitrate

    every 30 min (from -2 h to + 5 h during the test day)

Study Arms (2)

Nitrate

EXPERIMENTAL

Sodium nitrate ingestion prior to ingesting intrinsically labeled protein

Dietary Supplement: Nitrate

Sodium chloride

PLACEBO COMPARATOR

Sodium chloride placebo group

Dietary Supplement: Sodium chloride

Interventions

NitrateDIETARY_SUPPLEMENT

0.15 mmol/kg body weight sodium nitrate (dissolved in 250 mL water)

Nitrate
Sodium chlorideDIETARY_SUPPLEMENT

0.15 mmol sodium chloride dissolved in 250 mL water.

Sodium chloride

Eligibility Criteria

Age70 Years - 85 Years
Sexmale
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Male
  • Aged between 70-85 years
  • BMI \< 30 kg/m2
  • Non insulin-dependent diabetes mellitus type 2 patients (T2DM) ( \>1 y since diagnoses)

You may not qualify if:

  • Smoking
  • Hypertension (according to WHO criteria)\[29\] and/or cardiovascular disease treated with medication containing nitrates and/or having vasodilatory effects
  • Use of medication, except for oral blood glucose lowering medication
  • Use of insulin
  • All co-morbidities interacting with mobility and muscle metabolism of the lower limbs (e.g. arthritis, spasticity/rigidity, all neurological disorders and paralysis).
  • HbA1c \> 10.0% (86 mmol/mol)
  • Donated blood in last 3 months
  • Diagnosed impaired renal or liver function
  • Myocardial infarction within the last 3 years
  • Gastric acid inhibitors
  • Use of anti-coagulants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maastricht University

Maastricht, Limburg, 6229ER, Netherlands

Location

Related Publications (2)

  • Gorissen SHM, Trommelen J, Kouw IWK, Holwerda AM, Pennings B, Groen BBL, Wall BT, Churchward-Venne TA, Horstman AMH, Koopman R, Burd NA, Fuchs CJ, Dirks ML, Res PT, Senden JMG, Steijns JMJM, de Groot LCPGM, Verdijk LB, van Loon LJC. Protein Type, Protein Dose, and Age Modulate Dietary Protein Digestion and Phenylalanine Absorption Kinetics and Plasma Phenylalanine Availability in Humans. J Nutr. 2020 Aug 1;150(8):2041-2050. doi: 10.1093/jn/nxaa024.

  • Kouw IW, Gorissen SH, Burd NA, Cermak NM, Gijsen AP, van Kranenburg J, van Loon LJ. Postprandial Protein Handling Is Not Impaired in Type 2 Diabetes Patients When Compared With Normoglycemic Controls. J Clin Endocrinol Metab. 2015 Aug;100(8):3103-11. doi: 10.1210/jc.2015-1234. Epub 2015 Jun 2.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

NitratesSodium Chloride

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

AnionsIonsElectrolytesInorganic ChemicalsNitric AcidNitrogen CompoundsOrganic ChemicalsChloridesHydrochloric AcidChlorine CompoundsSodium Compounds

Study Officials

  • Luc van Loon, PhD

    Maastricht University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 3, 2011

First Posted

November 17, 2011

Study Start

August 1, 2011

Primary Completion

July 1, 2012

Study Completion

December 1, 2013

Last Updated

April 15, 2016

Record last verified: 2012-10

Data Sharing

IPD Sharing
Will not share

Locations